STOCK TITAN

[Form 4] KLA Corporation Insider Trading Activity

Filing Impact
(High)
Filing Sentiment
(Very Negative)
Form Type
4
Rhea-AI Filing Summary

Brian Lorig, Executive Vice President of KLA (KLAC), reported a sale of KLA common stock under a pre-established Rule 10b5-1 trading plan. The filing shows a sale on 08/12/2025 of 8,049 shares at $913.68 per share, executed pursuant to a 10b5-1 plan adopted May 2, 2025. After the reported sale the filing lists 11,479.006 shares beneficially owned, which includes 10,902.905 shares issuable upon vesting of restricted stock units (RSUs). The form is signed by an attorney-in-fact on behalf of Mr. Lorig on 08/14/2025.

Brian Lorig, Executive Vice President di KLA (KLAC), ha venduto azioni ordinarie della società nell'ambito di un piano di negoziazione predefinito ai sensi della Regola 10b5-1. La comunicazione indica una vendita effettuata il 12/08/2025 di 8.049 azioni a 913,68 USD ciascuna, eseguita in base a un piano 10b5-1 adottato il 2 maggio 2025. Dopo la vendita riportata, il documento elenca 11.479,006 azioni detenute in via beneficiaria, comprensive di 10.902,905 azioni che saranno emesse al momento della maturazione delle restricted stock units (RSU). Il modulo è firmato da un procuratore per conto del Sig. Lorig in data 14/08/2025.

Brian Lorig, vicepresidente ejecutivo de KLA (KLAC), comunicó la venta de acciones ordinarias de KLA bajo un plan de negociación preestablecido conforme a la Regla 10b5-1. El informe muestra una venta el 12/08/2025 de 8.049 acciones a 913,68 USD por acción, ejecutada conforme a un plan 10b5-1 adoptado el 2 de mayo de 2025. Tras la venta reportada, el documento lista 11.479,006 acciones de propiedad beneficiaria, que incluyen 10.902,905 acciones a emitir cuando se consoliden las restricted stock units (RSU). El formulario está firmado por un apoderado en nombre del Sr. Lorig el 14/08/2025.

KLA(KLAC)의 부사장(Executive Vice President) Brian Lorig는 사전에 설정된 Rule 10b5-1 거래계획에 따라 KLA 보통주를 매도했다고 보고했습니다. 제출서류에 따르면 2025-08-12에 주당 913.68달러에 8,049주를 매도했으며, 이는 2025년 5월 2일 채택된 10b5-1 계획에 따른 거래입니다. 보고된 매도 후 제출서류는 11,479.006주의 실질 소유주식을 기재하고 있으며, 이 중 10,902.905주는 제한주식단위(RSU)의 베스팅 시 발행될 주식입니다. 양식은 2025-08-14자로 Lorig 씨를 대신한 대리인이 서명했습니다.

Brian Lorig, Vice‑président exécutif de KLA (KLAC), a déclaré la vente d'actions ordinaires KLA dans le cadre d'un plan de négociation préétabli conforme à la règle 10b5-1. Le dossier indique une vente le 12/08/2025 de 8 049 actions à 913,68 USD chacune, exécutée en vertu d'un plan 10b5-1 adopté le 2 mai 2025. Après la vente déclarée, le formulaire indique la détention bénéficiaire de 11 479,006 actions, incluant 10 902,905 actions qui seront émises lors de la levée des restricted stock units (RSU). Le document est signé par un mandataire au nom de M. Lorig en date du 14/08/2025.

Brian Lorig, Executive Vice President von KLA (KLAC), meldete den Verkauf von KLA-Stammaktien im Rahmen eines vorab festgelegten Rule-10b5-1-Handelsplans. Die Einreichung weist einen Verkauf am 12.08.2025 von 8.049 Aktien zu je 913,68 USD aus, ausgeführt gemäß einem am 2. Mai 2025 angenommenen 10b5-1-Plan. Nach dem gemeldeten Verkauf listet die Einreichung 11.479,006 wirtschaftlich gehaltene Aktien auf, darunter 10.902,905 Aktien, die bei Vesting von Restricted Stock Units (RSUs) ausgegeben werden. Das Formular ist am 14.08.2025 von einem Bevollmächtigten im Namen von Herrn Lorig unterzeichnet worden.

Positive
  • None.
Negative
  • None.

Insights

Insider sale under a documented 10b5-1 plan; transaction size disclosed but does not by itself indicate firm performance issues.

The sale of 8,049 shares at $913.68 was executed under a 10b5-1 plan, which generally signals a pre-planned disposition rather than opportunistic insider trading. The filing clarifies post-sale beneficial ownership of 11,479.006 shares, largely composed of unvested RSUs (10,902.905 shares). For investors, the transaction is a transparency event but provides no direct evidence of company-wide financial stress or change in outlook because it follows a specified trading plan.

Proper use of a 10b5-1 plan and clear disclosure reflect compliance with insider-trading rules; timing and context remain routine.

The filing documents adoption of a 10b5-1 plan on May 2, 2025 and a subsequent sale consistent with that plan, demonstrating adherence to governance best practices for scheduled insider trades. The inclusion of RSU counts in beneficial ownership improves transparency. There is no indication in the filing of ad hoc or suspicious trading outside the plan.

Brian Lorig, Executive Vice President di KLA (KLAC), ha venduto azioni ordinarie della società nell'ambito di un piano di negoziazione predefinito ai sensi della Regola 10b5-1. La comunicazione indica una vendita effettuata il 12/08/2025 di 8.049 azioni a 913,68 USD ciascuna, eseguita in base a un piano 10b5-1 adottato il 2 maggio 2025. Dopo la vendita riportata, il documento elenca 11.479,006 azioni detenute in via beneficiaria, comprensive di 10.902,905 azioni che saranno emesse al momento della maturazione delle restricted stock units (RSU). Il modulo è firmato da un procuratore per conto del Sig. Lorig in data 14/08/2025.

Brian Lorig, vicepresidente ejecutivo de KLA (KLAC), comunicó la venta de acciones ordinarias de KLA bajo un plan de negociación preestablecido conforme a la Regla 10b5-1. El informe muestra una venta el 12/08/2025 de 8.049 acciones a 913,68 USD por acción, ejecutada conforme a un plan 10b5-1 adoptado el 2 de mayo de 2025. Tras la venta reportada, el documento lista 11.479,006 acciones de propiedad beneficiaria, que incluyen 10.902,905 acciones a emitir cuando se consoliden las restricted stock units (RSU). El formulario está firmado por un apoderado en nombre del Sr. Lorig el 14/08/2025.

KLA(KLAC)의 부사장(Executive Vice President) Brian Lorig는 사전에 설정된 Rule 10b5-1 거래계획에 따라 KLA 보통주를 매도했다고 보고했습니다. 제출서류에 따르면 2025-08-12에 주당 913.68달러에 8,049주를 매도했으며, 이는 2025년 5월 2일 채택된 10b5-1 계획에 따른 거래입니다. 보고된 매도 후 제출서류는 11,479.006주의 실질 소유주식을 기재하고 있으며, 이 중 10,902.905주는 제한주식단위(RSU)의 베스팅 시 발행될 주식입니다. 양식은 2025-08-14자로 Lorig 씨를 대신한 대리인이 서명했습니다.

Brian Lorig, Vice‑président exécutif de KLA (KLAC), a déclaré la vente d'actions ordinaires KLA dans le cadre d'un plan de négociation préétabli conforme à la règle 10b5-1. Le dossier indique une vente le 12/08/2025 de 8 049 actions à 913,68 USD chacune, exécutée en vertu d'un plan 10b5-1 adopté le 2 mai 2025. Après la vente déclarée, le formulaire indique la détention bénéficiaire de 11 479,006 actions, incluant 10 902,905 actions qui seront émises lors de la levée des restricted stock units (RSU). Le document est signé par un mandataire au nom de M. Lorig en date du 14/08/2025.

Brian Lorig, Executive Vice President von KLA (KLAC), meldete den Verkauf von KLA-Stammaktien im Rahmen eines vorab festgelegten Rule-10b5-1-Handelsplans. Die Einreichung weist einen Verkauf am 12.08.2025 von 8.049 Aktien zu je 913,68 USD aus, ausgeführt gemäß einem am 2. Mai 2025 angenommenen 10b5-1-Plan. Nach dem gemeldeten Verkauf listet die Einreichung 11.479,006 wirtschaftlich gehaltene Aktien auf, darunter 10.902,905 Aktien, die bei Vesting von Restricted Stock Units (RSUs) ausgegeben werden. Das Formular ist am 14.08.2025 von einem Bevollmächtigten im Namen von Herrn Lorig unterzeichnet worden.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Lorig Brian

(Last) (First) (Middle)
ONE TECHNOLOGY DRIVE

(Street)
MILPITAS CA 95035

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
KLA CORP [ KLAC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EVP, KLA Global Services
3. Date of Earliest Transaction (Month/Day/Year)
08/12/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/12/2025 S 8,049(1) D $913.68 11,479.006(2) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. This sale was effected pursuant to the terms of a Rule 10b5-1 trading plan adopted by the Reporting Person on May 2, 2025.
2. The number of shares of KLA common stock includes 10,902.905 shares issuable upon vesting of restricted stock units ("RSUs").
/s/ Jeffrey S. Cannon, as attorney-in-fact for Brian Lorig 08/14/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Kla Corp

NASDAQ:KLAC

KLAC Rankings

KLAC Latest News

KLAC Latest SEC Filings

KLAC Stock Data

125.29B
131.78M
0.09%
91.13%
2.37%
Semiconductor Equipment & Materials
Optical Instruments & Lenses
Link
United States
MILPITAS